<--- Back to Details
First PageDocument Content
Neurological disorders / Neuroanatomy / Neurodegenerative disorders / Rare diseases / Demyelinating disease / Dysautonomia / Central nervous system disease / Peripheral neuropathy / Encephalomyelitis / Health / Anatomy / Autoimmune diseases
Date: 2012-08-22 14:06:13
Neurological disorders
Neuroanatomy
Neurodegenerative disorders
Rare diseases
Demyelinating disease
Dysautonomia
Central nervous system disease
Peripheral neuropathy
Encephalomyelitis
Health
Anatomy
Autoimmune diseases

2013 MeSH Tree Structures. C10 - DISEASES-NEUROLOGIC

Add to Reading List

Source URL: www.nlm.nih.gov

Download Document from Source Website

File Size: 333,63 KB

Share Document on Facebook

Similar Documents

Effect of b-estradiol on myelination of neurons by oligodendrocytes in co-culture: a new long term in vitro model of central myelination ASENT, 14th Annual Meeting Washington, DC  Noelle Callizot, Maud Combes, Sylvain Ei

Effect of b-estradiol on myelination of neurons by oligodendrocytes in co-culture: a new long term in vitro model of central myelination ASENT, 14th Annual Meeting Washington, DC Noelle Callizot, Maud Combes, Sylvain Ei

DocID: 1qsNr - View Document

Medical Hypotheses Medical Hypotheses,  © Longman Group UK Ltd 1992 Multiple Sclerosis: Prevention of Serious Illness Vision of a Desired Future for Newly Ascertained Patients

Medical Hypotheses Medical Hypotheses, © Longman Group UK Ltd 1992 Multiple Sclerosis: Prevention of Serious Illness Vision of a Desired Future for Newly Ascertained Patients

DocID: 1oWBq - View Document

oms of demyelinating disorders. Prescribers g the use of ACTEMRA in patients with ating disorders. Impairment mmended in patients with active hepatic disease

oms of demyelinating disorders. Prescribers g the use of ACTEMRA in patients with ating disorders. Impairment mmended in patients with active hepatic disease

DocID: 1df3Z - View Document

oms of demyelinating disorders. Prescribers g the use of ACTEMRA in patients with preexisting ers. Impairment mmended in patients with active hepatic disease

oms of demyelinating disorders. Prescribers g the use of ACTEMRA in patients with preexisting ers. Impairment mmended in patients with active hepatic disease

DocID: 1bIMJ - View Document

MULTIPLE SCLEROSIS Multiple Sclerosis Jun Yan July 2012 Multiple sclerosis (MS) means multiple scars or lesions. It is a chronic inflammatory demyelinating disease of the central nervous system (CNS). CNS consists of the

MULTIPLE SCLEROSIS Multiple Sclerosis Jun Yan July 2012 Multiple sclerosis (MS) means multiple scars or lesions. It is a chronic inflammatory demyelinating disease of the central nervous system (CNS). CNS consists of the

DocID: 195pb - View Document